The FDA is set to release 8 new guidance documents on AI in medical devices by early 2027, signaling a pivotal shift in regulatory oversight. This article delves into the anticipated impact on manufacturers, developers, and healthcare providers, emphasizing safety, efficacy, and responsible innovation.